Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer

Histologic transformation to small cell neuroendocrine prostate cancer occurs in a subset of patients with advanced prostate cancer as a mechanism of treatment resistance. Rovalpituzumab tesirine (SC16LD6.5) is an antibody-drug conjugate that targets delta-like protein 3 (DLL3) and was initially dev...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Sci Transl Med
Autori principali: Puca, Loredana, Gavyert, Katie, Sailer, Verena, Conteduca, Vincenza, Dardenne, Etienne, Sigouros, Michael, Isse, Kumiko, Kearney, Megan, Vosoughi, Aram, Fernandez, Luisa, Pan, Heng, Motanagh, Samaneh, Hess, Judy, Donoghue, Adam J., Sboner, Andrea, Wang, Yuzhuo, Dittamore, Ryan, Rickman, David, Nanus, David M., Tagawa, Scott T., Elemento, Olivier, Mosquera, Juan Miguel, Saunders, Laura, Beltran, Himisha
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6525633/
https://ncbi.nlm.nih.gov/pubmed/30894499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aav0891
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi